{
  "input": {
    "mode": "execute_actions",
    "query": {
      "entity": "Neurotransmitter disorders",
      "relation": "indication"
    },
    "items": [
      {
        "hypothesis_id": "H1",
        "graph_actions": [
          {
            "type": "add_mechanism_link",
            "from": "Drug",
            "via": [
              "Neurotransmitter"
            ],
            "to": "Disease",
            "success_criteria": "形成至少2条不相交路径",
            "assignee": "Proponent"
          }
        ]
      }
    ],
    "tegraph_snapshot": {
      "nodes": [
        {
          "id": "drug_levodopa",
          "type": "Drug",
          "label": "Levodopa",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_rasagiline",
          "type": "Drug",
          "label": "Rasagiline",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_selegiline",
          "type": "Drug",
          "label": "Selegiline",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_amantadine",
          "type": "Drug",
          "label": "Amantadine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_tetrabenazine",
          "type": "Drug",
          "label": "Tetrabenazine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_methylphenidate",
          "type": "Drug",
          "label": "Methylphenidate",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_dextroamphetamine",
          "type": "Drug",
          "label": "Dextroamphetamine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_clonidine",
          "type": "Drug",
          "label": "Clonidine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_buspirone",
          "type": "Drug",
          "label": "Buspirone",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_aripiprazole",
          "type": "Drug",
          "label": "Aripiprazole",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_desvenlafaxine",
          "type": "Drug",
          "label": "Desvenlafaxine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_atomoxetine",
          "type": "Drug",
          "label": "Atomoxetine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_nt_disorders",
          "type": "Disease",
          "label": "Neurotransmitter disorders",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_ot1",
          "type": "Target",
          "label": "OffTarget1",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot2",
          "type": "Target",
          "label": "OffTarget2",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp1",
          "type": "Pathway",
          "label": "RiskPathway1",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp2",
          "type": "Pathway",
          "label": "RiskPathway2",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv1",
          "type": "Phenotype",
          "label": "AdversePhenotype1",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv2",
          "type": "Phenotype",
          "label": "AdversePhenotype2",
          "attrs": {
            "agent": "Skeptic"
          }
        }
      ],
      "edges": [
        {
          "source": "drug_levodopa",
          "target": "n_nt_disorders",
          "relation": "supports",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "用于多种神经递质疾病的经典药物"
        },
        {
          "source": "drug_rasagiline",
          "target": "n_nt_disorders",
          "relation": "supports",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "对帕金森病有良好效果"
        },
        {
          "source": "drug_selegiline",
          "target": "n_nt_disorders",
          "relation": "supports",
          "weight": 0.78,
          "agent": "Proponent",
          "rationale": "常用于抑郁及帕金森的治疗"
        },
        {
          "source": "drug_amantadine",
          "target": "n_nt_disorders",
          "relation": "supports",
          "weight": 0.76,
          "agent": "Proponent",
          "rationale": "有助于帕金森症状改善"
        },
        {
          "source": "drug_tetrabenazine",
          "target": "n_nt_disorders",
          "relation": "supports",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "用于运动障碍，尤其是亨廷顿病"
        },
        {
          "source": "drug_methylphenidate",
          "target": "n_nt_disorders",
          "relation": "supports",
          "weight": 0.72,
          "agent": "Proponent",
          "rationale": "用于多动症，影响神经递质"
        },
        {
          "source": "drug_dextroamphetamine",
          "target": "n_nt_disorders",
          "relation": "supports",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "用于注意缺陷多动障碍的治疗"
        },
        {
          "source": "drug_clonidine",
          "target": "n_nt_disorders",
          "relation": "supports",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "用于抗抑郁及焦虑"
        },
        {
          "source": "drug_buspirone",
          "target": "n_nt_disorders",
          "relation": "supports",
          "weight": 0.63,
          "agent": "Proponent",
          "rationale": "用于焦虑症的治疗"
        },
        {
          "source": "drug_aripiprazole",
          "target": "n_nt_disorders",
          "relation": "supports",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "用于精神分裂症及双相障碍"
        },
        {
          "source": "drug_desvenlafaxine",
          "target": "n_nt_disorders",
          "relation": "supports",
          "weight": 0.58,
          "agent": "Proponent",
          "rationale": "抗抑郁药，影响神经递质"
        },
        {
          "source": "drug_atomoxetine",
          "target": "n_nt_disorders",
          "relation": "supports",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "用于注意缺陷多动障碍"
        },
        {
          "source": "drug_levodopa",
          "target": "n_ot1",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的旁路作用"
        },
        {
          "source": "drug_rasagiline",
          "target": "n_ot1",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的旁路作用"
        },
        {
          "source": "drug_selegiline",
          "target": "n_ot2",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的旁路作用"
        },
        {
          "source": "n_ot1",
          "target": "n_rp1",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "风险通路关联"
        },
        {
          "source": "n_ot2",
          "target": "n_rp2",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "风险通路关联"
        },
        {
          "source": "n_rp1",
          "target": "n_adv1",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "导致不良表型"
        },
        {
          "source": "n_rp2",
          "target": "n_adv2",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "导致不良表型"
        },
        {
          "source": "n_adv1",
          "target": "H1",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "若该风险成立，将抵消净获益"
        },
        {
          "source": "n_adv2",
          "target": "H2",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "若该风险成立，将抵消净获益"
        }
      ],
      "round_index": 4
    },
    "constraints": {
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    }
  },
  "output": {
    "hypothesis_id": "H1",
    "executed_actions": [
      {
        "action_ref": 0,
        "status": "done",
        "graph_updates": {
          "add_nodes": [
            {
              "id": "n_dopamine_target",
              "type": "Target",
              "label": "Dopamine Receptor",
              "attrs": {
                "agent": "Proponent"
              }
            },
            {
              "id": "n_serotonin_target",
              "type": "Target",
              "label": "Serotonin Receptor",
              "attrs": {
                "agent": "Proponent"
              }
            },
            {
              "id": "n_pathway_dopamine",
              "type": "Pathway",
              "label": "Dopamine Pathway",
              "attrs": {
                "agent": "Proponent"
              }
            },
            {
              "id": "n_pathway_serotonin",
              "type": "Pathway",
              "label": "Serotonin Pathway",
              "attrs": {
                "agent": "Proponent"
              }
            }
          ],
          "add_edges": [
            {
              "source": "drug_levodopa",
              "target": "n_dopamine_target",
              "relation": "acts_on",
              "weight": 0.85,
              "agent": "Proponent",
              "rationale": "直接作用于多巴胺受体"
            },
            {
              "source": "drug_rasagiline",
              "target": "n_dopamine_target",
              "relation": "acts_on",
              "weight": 0.8,
              "agent": "Proponent",
              "rationale": "通过抑制单胺氧化酶增加多巴胺"
            },
            {
              "source": "drug_selegiline",
              "target": "n_dopamine_target",
              "relation": "acts_on",
              "weight": 0.75,
              "agent": "Proponent",
              "rationale": "增加多巴胺活性"
            },
            {
              "source": "drug_methylphenidate",
              "target": "n_dopamine_target",
              "relation": "acts_on",
              "weight": 0.72,
              "agent": "Proponent",
              "rationale": "通过影响多巴胺系统"
            },
            {
              "source": "n_dopamine_target",
              "target": "n_pathway_dopamine",
              "relation": "involved_in",
              "weight": 0.7,
              "agent": "Proponent",
              "rationale": "多巴胺通路的关键部件"
            },
            {
              "source": "drug_buspirone",
              "target": "n_serotonin_target",
              "relation": "acts_on",
              "weight": 0.65,
              "agent": "Proponent",
              "rationale": "影响血清素受体活性"
            },
            {
              "source": "drug_desvenlafaxine",
              "target": "n_serotonin_target",
              "relation": "acts_on",
              "weight": 0.63,
              "agent": "Proponent",
              "rationale": "用作多种抑郁症药物"
            },
            {
              "source": "n_serotonin_target",
              "target": "n_pathway_serotonin",
              "relation": "involved_in",
              "weight": 0.68,
              "agent": "Proponent",
              "rationale": "血清素相关通路的关键部件"
            },
            {
              "source": "n_pathway_dopamine",
              "target": "n_nt_disorders",
              "relation": "causes",
              "weight": 0.75,
              "agent": "Proponent",
              "rationale": "影响神经递质疾病"
            },
            {
              "source": "n_pathway_serotonin",
              "target": "n_nt_disorders",
              "relation": "causes",
              "weight": 0.7,
              "agent": "Proponent",
              "rationale": "影响神经递质疾病"
            }
          ],
          "merge": [],
          "set_weights": []
        },
        "notes": "已建立 Drug → Target → Pathway → Disease 的两条不相交路径"
      }
    ],
    "unexecuted_actions": [],
    "residual_gaps": [
      "仍需评估沿用的药物的安全性与副作用"
    ]
  }
}